These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 4660362)

  • 21. [Adrenergic beta blockaders in hyperthyroidism (adrenergic beta block with propranolol as the sole preparatory treatment of hyperthyroidism in parital thyroidectomy].
    Ramírez Del Villar E; Wurst Zevallos G; Bouroncle Carreón M; Uribe LJ
    Rev Neuropsiquiatr; 1973 Jun; 36(2):107-16. PubMed ID: 4793306
    [No Abstract]   [Full Text] [Related]  

  • 22. [Use of propranolol in coronary insufficiency and in some cardiac arrhythmias].
    Zavala Jurado A; Gonzalez Martin A; De Feuillade ND; Liñan JM
    Prensa Med Argent; 1968 Aug; 55(26):1271-8. PubMed ID: 4974565
    [No Abstract]   [Full Text] [Related]  

  • 23. [The use of propanolol in the complex treatment of thyrotoxicosis].
    Daskalov T; Khristov Kh
    Vutr Boles; 1971; 10(6):83-8. PubMed ID: 5156117
    [No Abstract]   [Full Text] [Related]  

  • 24. [Beta-adrenergetic blockade in the treatment of thyrotoxicosis].
    Noskowicz T; Musial M
    Endokrynol Pol; 1968; 19(1):21-8. PubMed ID: 4875925
    [No Abstract]   [Full Text] [Related]  

  • 25. [The beta-blocking drugs in hyperthyroidism. 2. Effects on metabolic and biochemical changes].
    De Gregori ME; Bellotti G; Ghidini O; Giardina F; Mantovanelli S
    Minerva Med; 1971 Mar; 62(26):1374-82. PubMed ID: 5554155
    [No Abstract]   [Full Text] [Related]  

  • 26. The effect of propranolol, atenolol and metoprolol on the serum levels of thyroxin (T4) and triiodothyronine (T3).
    Shikara MM; Maniar R; Steier W; Rao S; Gintautas J
    Proc West Pharmacol Soc; 2003; 46():127. PubMed ID: 14699907
    [No Abstract]   [Full Text] [Related]  

  • 27. Propranolol and 131-I for thyrotoxicosis.
    Cohen GF
    Lancet; 1968 Dec; 2(7582):1349-50. PubMed ID: 4177417
    [No Abstract]   [Full Text] [Related]  

  • 28. Controlled trial of propranolol in thyrotoxicosis.
    Shanks RG; Hadden DR; Lowe DC; McDevitt DG; Montgomery DA
    Lancet; 1969 May; 1(7603):993-4. PubMed ID: 4181181
    [No Abstract]   [Full Text] [Related]  

  • 29. Propranolol: an adjunct to definitive treatment of thyrotoxicosis.
    Friedenberg RC
    Rocky Mt Med J; 1971 Sep; 68(9):41-3. PubMed ID: 5096714
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of adrenergic receptor blockade of the tachycardia of thyrotoxicosis and anxiety state.
    Turner P; Granville-Grossman KL
    Lancet; 1965 Dec; 2(7426):1316-8. PubMed ID: 4165805
    [No Abstract]   [Full Text] [Related]  

  • 31. [Evaluation of the inotropic effect of calcium chloride and caffeine on the myocardium in patients with thyrotoxicosis].
    Rom-Bugoslavs'ka OS
    Fiziol Zh; 1973; 19(3):402-6. PubMed ID: 4762518
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of conservative treatment of hyperthyroidism on the excretion of peptide hydroxyproline].
    Najmowicz-Dabrowa H; Barańska H; Iwańska J
    Pol Tyg Lek; 1976 Jan; 31(1):5-7. PubMed ID: 1250746
    [No Abstract]   [Full Text] [Related]  

  • 33. [Hypercalcemia as first manifestation of thyrotoxicosis (author's transl)].
    Webb Youdale S; Gatell Artigas JM; Soriano Marín E; Garcíca San Miquel J
    Med Clin (Barc); 1980 Feb; 74(3):107-8. PubMed ID: 7366271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical manifestations of hyperthyroidism after treatment with selective beta 1 adrenoceptor blocking agents.
    Shikara MM; Polena S; Solinas A; Sanghvi K; Gintautas J
    Proc West Pharmacol Soc; 2003; 46():125-6. PubMed ID: 14699906
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment with thyrotoxicosis with sympatholytic drugs.
    Bell RL
    J Tenn Med Assoc; 1976 Mar; 69(3):200. PubMed ID: 1256053
    [No Abstract]   [Full Text] [Related]  

  • 36. [Dependence of the inhibitory effect of Inderal on the increase in heart rate].
    Walecka E; Kosowski Z; Romanowska-Górecka B
    Wiad Lek; 1971 Jul; 24(3):189-92. PubMed ID: 5548716
    [No Abstract]   [Full Text] [Related]  

  • 37. [Preoperative preparation of patients with hyperthyroidism using propranolol].
    Maunand B; Varroud-Vial M
    Nouv Presse Med; 1980 Oct; 9(37):2744. PubMed ID: 7433084
    [No Abstract]   [Full Text] [Related]  

  • 38. Propanolol and 131-I in the treatment of diffuse thyroid hyperplasia with hyperthyroidism.
    Franco J; Coppler M; Kovaleski B
    J Nucl Med; 1970 May; 11(5):219-20. PubMed ID: 5444005
    [No Abstract]   [Full Text] [Related]  

  • 39. [On the action of propranolol on the phases of cardiac dynamics in normal, myocardiosclerotic and hypersympathicotonic subjects].
    Lixi M; Camoglio E; Sassu P; Biddau C; Porrazzo G; Raffo M; Cherchi A
    Boll Soc Ital Cardiol; 1966; 11(4):1510-22. PubMed ID: 5992067
    [No Abstract]   [Full Text] [Related]  

  • 40. The influence of pre-operative drug therapy on lymphoid tissue in patients with primary thyrotoxicosis.
    Simpson JG; Young RJ; Gray ES; Nicol AG; Michie W; Pegg CA; Beck JS
    J Pathol; 1973 Jan; 109(1):P8. PubMed ID: 4719742
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.